<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-06</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-06</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>57</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
*   <strong>Perturb-seq</strong>ï¼šå•ç»†èƒä¸CRISPRç»“åˆï¼Œæˆä¸ºç ”ç©¶åŸºå› åŠŸèƒ½å’Œç–¾ç—…æœºåˆ¶çš„æ–°ç¥å™¨ã€‚<br />
*   <strong>ç—…æ¯’ä¸ç™Œç—‡å¤å‘</strong>ï¼šNatureé‡ç£…å‘ç°æµæ„Ÿå’Œæ–°å† ç—…æ¯’å¯æ¿€æ´»ä¼‘çœ ç™Œç»†èƒï¼Œä¿ƒè¿›å¤å‘ã€è½¬ç§»åŠæ­»äº¡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>å…ç–«ç»†èƒä»£è°¢è°ƒæ§</strong>ï¼šæ·±å…¥è§£æè‡ªèº«å…ç–«æ€§ç–¾ç—…ä¸­å…ç–«ç»†èƒçš„ä»£è°¢è°ƒæ§æœºåˆ¶ã€‚<br />
*   <strong>ç©ºé—´è½¬å½•ç»„å­¦ä¸AI</strong>ï¼šåˆ©ç”¨AIé©±åŠ¨çš„ç©ºé—´ç»†èƒè¡¨å‹ç»„å­¦æå‡éå°ç»†èƒè‚ºç™Œé£é™©åˆ†å±‚ã€‚<br />
*   <strong>ä»£è°¢ç»„å­¦ç ”ç©¶æ€è·¯</strong>ï¼šæä¾›ç”³è¯·å›½è‡ªç„¶åŸºé‡‘çš„ä»£è°¢ç»„å­¦é«˜ç«¯ç ”ç©¶æ€è·¯ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>GSAæ•°æ®åº“</strong>ï¼šå›½å®¶ç”Ÿç‰©ä¿¡æ¯ä¸­å¿ƒæä¾›çš„ç»„å­¦åŸå§‹æ•°æ®å½’æ¡£åº“ï¼Œæ”¯æŒæ•°æ®å…±äº«ä¸åˆ†æã€‚<br />
*   <strong>Cell Ranger</strong>ï¼šç”¨äº10xå•ç»†èƒæ•°æ®åˆ†æçš„è½¯ä»¶ï¼Œæä¾›ä¸‹è½½ä¸é…ç½®æŒ‡å¯¼ã€‚<br />
*   <strong>metasensåŒ…</strong>ï¼šç”¨äºMetaåˆ†æçš„åå€šæ£€æµ‹å·¥å…·ï¼Œå¼•å…¥LFKä¸å¯¹ç§°æ€§æŒ‡æ•°æ£€éªŒå’ŒDoiå›¾ï¼Œè¡¥å……æˆ–æ›¿ä»£ä¼ ç»Ÿæ–¹æ³•ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å¤šç»„å­¦æŠ€æœ¯ï¼ˆå¦‚å•ç»†èƒè½¬å½•ç»„ã€ç©ºé—´è½¬å½•ç»„ã€è¡¨è§‚é—ä¼ ç»„ï¼‰åœ¨è§£æå¤æ‚ç”Ÿç‰©ä½“ç³»ï¼ˆå¦‚å…ç–«ç»†èƒå¯¹ç—…æ¯’/åŒ–å­¦æš´éœ²çš„ååº”ã€è‚¿ç˜¤å¾®ç¯å¢ƒçš„é‡å¡‘ã€èƒšèƒå‘è‚²ã€ç»„ç»‡ç–¾ç—…æœºåˆ¶ï¼‰ä¸­å±•ç°å‡ºå¼ºå¤§çš„èƒ½åŠ›ï¼Œä¸ºç–¾ç—…æ²»ç–—å’Œç”Ÿç‰©å­¦æœºåˆ¶ç ”ç©¶æä¾›æ–°è§†è§’ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>ç»†èƒè°±ç³»ä¸å‘è‚²æœºåˆ¶</strong>ï¼šæ­ç¤ºå¤šèƒ½å¹²ç»†èƒçš„åˆ†åŒ–æ½œèƒ½å’Œè°±ç³»å‘½è¿ï¼ˆGSE272588ï¼‰ï¼Œä»¥åŠèƒšèƒå‘è‚²è¿‡ç¨‹ä¸­çš„ç»„è›‹ç™½ä¿®é¥°åŠ¨æ€ï¼ˆGSE293415ï¼‰ã€‚<br />
*   <strong>ç–¾ç—…ä¸å¾®ç¯å¢ƒäº’ä½œ</strong>ï¼šæ·±å…¥è§£ææ…¢æ€§å‹åŠ›å¯¹è‚è„å…ç–«çš„å½±å“åŠè‚ç™Œå‘ç”Ÿæœºåˆ¶ï¼ˆGSE305657, GSE243826, GSE244213, GSE242831ï¼‰ï¼Œä»¥åŠè‚¿ç˜¤å¾®ç¯å¢ƒçš„é‡å¡‘ä¸å…ç–«é€ƒé€¸ï¼ˆGSE288484, GSE281103ï¼‰ã€‚<br />
*   <strong>ç»„ç»‡ç‰¹å¼‚æ€§ä¸ç‰©ç§å·®å¼‚</strong>ï¼šç ”ç©¶è„‚è‚ªå‰ä½“ç»†èƒçš„å‘è‚²å·®å¼‚ï¼ˆGSE305686ï¼‰ã€ç±»å™¨å®˜ç”Ÿæˆï¼ˆGSE309248ï¼‰ï¼Œä»¥åŠç‰©ç§ç‰¹å¼‚æ€§åŸºå› åœ¨è¯ç‰©ä»£è°¢ä¸­çš„ä½œç”¨ï¼ˆGSE295294ï¼‰ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆå•ç»†èƒè½¬å½•ç»„ã€è¡¨è§‚é—ä¼ ç»„ã€ç©ºé—´è½¬å½•ç»„ç­‰æŠ€æœ¯ï¼Œå®ç°å¯¹å¤æ‚ç”Ÿç‰©æ ·æœ¬çš„ç²¾ç»†è§£æã€‚<br />
*   <strong>æ–°å‹RNAä¿®é¥°ç ”ç©¶</strong>ï¼šæ¢ç´¢RNAä¿®é¥°ï¼ˆå¦‚ä¹³é…¸åŒ–ã€å‡å°¿å˜§å•¶åŒ–ï¼‰åœ¨ç–¾ç—…è¿›å±•ä¸­çš„ä½œç”¨ï¼ˆGSE306588, GSE217688ï¼‰ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡æ­ç¤ºä¸‰ç”²åŸºé¸Ÿè‹·åˆé…¶ 1 (TGS1) åœ¨èƒ°è…ºç™Œ (PAAD) ä¸­ä½œä¸ºåŒæºé‡ç»„ (HR) ä¿®å¤çš„å…³é”®ä»‹è´¨ï¼Œå¹¶æŒ‡å‡ºå…¶æ˜¯ PAAD å¯¹é—ä¼ æ¯’æ€§ç–—æ³•è€è¯æ€§çš„é‡è¦é©±åŠ¨å› ç´ ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- é˜æ˜ TGS1 åœ¨ PAAD ç»†èƒä¸­ä»‹å¯¼ HR ä¿®å¤çš„å…·ä½“åˆ†å­æœºåˆ¶ã€‚<br />
- é¶å‘ ATM-TGS1-BRCA1 è½´ï¼Œå¼€å‘å…‹æœ PAAD é—ä¼ æ¯’æ€§æ²»ç–—è€è¯æ€§çš„æ–°å‹è”åˆç–—æ³•ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é¦–æ¬¡å‘ç° TGS1 åœ¨ PAAD ç»†èƒä¸­å…·æœ‰é RNA ä¿®é¥°åŠŸèƒ½ï¼Œä½œä¸º HR ä¿®å¤çš„å…³é”®è°ƒæ§å› å­ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
Answer ALS and ALS TDI é¦–æ¬¡æ•´åˆè¶…2500åALSæ‚£è€…çš„å¤šç»„å­¦æ•°æ®åˆ°Neuromineå¹³å°ï¼Œä¸ºRNAæµ‹åºå’Œå¤šç»„å­¦ç ”ç©¶æä¾›æµ·é‡èµ„æºï¼ŒåŠ é€ŸALSç–—æ³•ç ”å‘ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç¥ç»é€€è¡Œæ€§ç–¾ç—…ï¼ˆALSï¼‰æ‚£è€…å¤šç»„å­¦æ•°æ®æ•´åˆä¸åˆ†æ<br />
- RNAå‰ªæ¥å› å­æ´»æ€§ä¸è°ƒæ§é¶ç‚¹æ¨æ–­<br />
- ç»„ç»‡å†…ç»†èƒç©ºé—´ç»„ç»‡ç»“æ„ä¸åŸºå› è¡¨è¾¾å…³ç³»è§£æ</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- KATMAPï¼šåˆ©ç”¨RNAæµ‹åºæ¨æ–­å‰ªæ¥å› å­æ´»æ€§ä¸è°ƒæ§é¶ç‚¹ã€‚<br />
- Nicheformerï¼šç»“åˆRNAæµ‹åºä¸ç©ºé—´è½¬å½•ç»„å­¦ï¼Œé‡å»ºç»†èƒå¾®ç¯å¢ƒï¼Œæ­ç¤ºç»„ç»‡ç»“æ„ä¸åŸºå› è¡¨è¾¾ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (13æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSA - ç»„å­¦æµ‹åºåŸå§‹æ•°æ®åº“ã€å›½å®¶ç”Ÿç‰©ä¿¡æ¯ä¸­å¿ƒã€‘</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡èœé¸Ÿå›¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæµ‹åºã€ç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç»„å­¦åŸå§‹æ•°æ®å½’æ¡£åº“ï¼ˆGenome Sequence Archive, GSAï¼‰æ˜¯é¢å‘ç»„å­¦é¢†åŸŸçš„åŸå§‹æ•°æ®é‡‡é›†ã€å­˜<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247537872&amp;idx=1&amp;sn=8f9fcb051dc53cb14e8998eaad85aed1" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>10xå•ç»†èƒåˆ†æç¬¬ä¸€æ­¥ï¼šCell Rangerä¸‹è½½+é…ç½®</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€10x<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šcellrangerè½¯ä»¶ç®€ä»‹ wgetä¸‹è½½å®‰è£…cellranger æ·»åŠ ç¯å¢ƒè·¯å¾„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533506&amp;idx=1&amp;sn=71b761adfa0c5cc533444d7f31f247c3" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>è¯¦è§£ï¼šè‡ªèº«å…ç–«æ€§ç–¾ç—…ä¸­å…ç–«ç»†èƒçš„ä»£è°¢è°ƒæ§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°æä»£è°¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè‡ªèº«å…ç–«æ€§ç–¾ç—…ä¸­å…ç–«ç»†èƒçš„ä»£è°¢è°ƒæ§æ˜¯ä¸€ä¸ªå¤æ‚è€Œç²¾ç»†çš„è¿‡ç¨‹ï¼Œæ¶‰åŠå¤šç§å…ç–«ç»†èƒç±»å‹ã€ä»£è°¢é€”å¾„å’Œè°ƒæ§åˆ†å­ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247483985&amp;idx=1&amp;sn=c0facca02ee42b23d96811eb5fc8d42c" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>è„šæœ¬æ›´æ–°--é«˜ç²¾åº¦ç©ºé—´è½¬å½•ç»„cell_niches</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒç©ºé—´äº¤å“ä¹<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè„šæœ¬æ›´æ–°--é«˜ç²¾åº¦ç©ºé—´è½¬å½•ç»„cell niches<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498756&amp;idx=1&amp;sn=ba82baa422cce50119351e8eff1bd281" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ç»¼è¿° | Brief.Bioinform. | ç”Ÿç‰©ä¿¡æ¯å­¦ä¸­çš„åˆ†å¸ƒå¤–å­¦ä¹ ï¼šè¿›å±•ä¸æŒ‘æˆ˜</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247502751&amp;idx=2&amp;sn=6441038ff11b5212bd7cb730b7758faf" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>Cellé¦–å‘ï¼šå•ç»†èƒ Ã— CRISPR = Perturb-seqï¼Œæœºåˆ¶ç ”ç©¶ç¥å™¨ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°åšå£«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490321&amp;idx=1&amp;sn=20f9a98ce20495c57a641534c81a2ee6" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>Natureé‡ç£…å‘ç°ï¼šæµæ„Ÿå’Œæ–°å† ç—…æ¯’ä¼šè®©ä¼‘çœ ä¸­ç™Œç»†èƒè‹é†’ï¼Œä¿ƒè¿›ç™Œç—‡çš„å¤å‘ã€è½¬ç§»å’Œæ­»äº¡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šé£Ÿç®¡ç™Œå‰æ²¿<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMzA3ODcxMA==&amp;mid=2656189762&amp;idx=1&amp;sn=228f4e37224f59e6c24781bd4b6c22b5" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>é£Ÿç®¡é³ç™Œæ–°è¾…åŠ©å…ç–«åŠ åŒ–ç–—ä¸¤å‘¨æœŸä¸ä¸‰å‘¨æœŸçš„ç–—æ•ˆå’Œå®‰å…¨æ€§æ¯”è¾ƒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šé£Ÿç®¡ç™Œå‰æ²¿<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMzA3ODcxMA==&amp;mid=2656189967&amp;idx=1&amp;sn=432f66debbc4dcd0515640c2b8d33f47" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>metasens åŒ…ç”¨äº metaåˆ†æä¸­çš„æ•æ„Ÿæ€§åˆ†æ:LFK ä¸å¯¹ç§°æ€§æŒ‡æ•°æ£€éªŒå’ŒDoi å›¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šR å­¦ä¹ è·µè¡Œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šLFK ä¸å¯¹ç§°æ€§æŒ‡æ•°æ£€éªŒ å’Œ Doi å›¾ï¼ˆDoi Plotï¼‰ æ˜¯ä¸€ç»„ æ–°å‹çš„åå€šæ£€æµ‹å·¥å…·ï¼Œè¿‘å¹´æ¥åœ¨ Meta åˆ†ææ–¹æ³•å­¦ä¸­é€æ¸å–ä»£æˆ–è¡¥å……ä¼ ç»Ÿçš„ æ¼æ–—å›¾ï¼ˆfunnel plotï¼‰ ä¸ Eggerâ€™s testã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493104&amp;idx=1&amp;sn=c7e1e508e56a40b8c2c6c4ae764acec0" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>pythonå•ç»†èƒå­¦ä¹ ï¼šï¼ˆIF=48.8ï¼‰é¡¶åˆŠæ‚å¿—å¤ç°ï¼ˆä¸€ï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡æŠ€èƒ½æ ‘<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæ–°çš„ä¸€ç¯‡pythonå•ç»†èƒå¼€å§‹å­¦ä¹ äº†ï¼Œæ¥ï¼<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546675&amp;idx=1&amp;sn=09db56d931f3e7d8885cac66d91cf0d1" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 3 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (40æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE305686 å•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºç‰›è‚Œå†…è„‚è‚ªå’Œçš®ä¸‹è„‚è‚ªä¸­è„‚è‚ªç¥–ç»†èƒçš„å‘è‚²é˜¶æ®µå’Œæ•°é‡å­˜åœ¨æ˜¾è‘—å·®å¼‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€immuneã€immunityã€TMEã€cardiovascularã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhendong Tan ; Pengcheng Lyu ; Honglin JiangSeries Type : Expression profiling by high throughput sequencingOrganism : Bos taurusBackground: Intramuscular fat (IMF), the white adipose tissue deposited between skeletal muscle fibers, is a key determinant of beef quality due to its contribution to meat, flavor, juiciness and tenderness. However, IMF develops later and grows more slowly, compared to other fat depots such as subcutaneous fat (SF) in cattle. The cellular and molecular mechanisms underlying the delayed development and slower growth of IMF compared to other fat depots remain poorly understood. Results: We performed single-cell RNA sequencing (scRNA-seq) on the stromal vascular fractions (SVFs) from IMF and SF of adult Angus crossbred steers as well as the mononuclear cell fractions (MCFs) from skeletal muscles of newborn Angus crossbred bull calves, with each tissue type collected from two animals. A total of 14,802 cells from 6 animals were sequenced. A clustering analysis revealed that these cells comprised ten cell types, including adipose progenitor cells (APCs), muscle satellite cells (MuSCs), myoblasts, smooth muscle cells, and various immune cell populations. The SF SVF from adult cattle harbored a significantly higher proportion of APCs than the IMF SVF. The MCFs from newborn calves did not contain detectable APCs. A subclustering analysis revealed that the APCs comprised six subpopulations (C0â€“C5), among which C3 and C5 were absent in the IMF SVF while C1 was markedly less abundant in the IMF SVF than the SF SVF. A gene set variation analysis and a pseudotime trajectory analysis showed that C1 and C3 represented more differentiated APCs, with higher expression of genes involved in adipogenesis, such as PPARG, ADAM12, and PPARGC1A, whereas subclusters C0 and C4 represented undifferentiated, uncommitted APCs, with higher expression of genes involved in DNA replication and cell adhesion, compared to the other subclusters. Conclusions: Overall, this single-cell transcriptomics study suggests two major differences in APCs between IMF and SF in adult cattle: (1) IMF contains fewer APCs than SF; (2) APCs in IMF are adipogenically less committed and differentiated compared to APCs in SF. These differences may explain why IMF develops later and grows more slowly than SF in cattle. This study also suggests that, in cattle, intramuscular fat begins to develop postnatally, challenging the widely held belief that it forms during late g...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305686" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE272588ï¼šå…·æœ‰ä¸åŒå…‹éš†è°±ç³»å‘½è¿ã€è½¬å½•ç»„å’Œè¡¨é¢æ ‡å¿—ç‰©çš„å¤šèƒ½ç¥–ç»†èƒäº§ç”Ÿä¸¤æ£µé€ è¡€æ ‘</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€scRNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fuwei Shang ; Xi Wang ; Hans-Reimer RodewaldSeries Type : Other ; Expression profiling by high throughput sequencingOrganism : Mus musculusMultipotent progenitors (MPP) are the quantitative source of native hematopoiesis that have been thought to be replenished slowly by hematopoietic stem cells (HSC). However, recent fate mapping studies have revealed two developmentally distinct populations of MPP, HSC-derived MPP (hMPP), and HSC-independent, embryonic MPP (eMPP). These data raise fundamental questions on the distinctions and functions of these progenitors. Here, we mapped the clonal dynamics of the two independent MPP systems, using in situ barcoding, and barcode linkage (hMPP), or disconnect (eMPP), with HSC. The cumulative output of eMPP to hematopoiesis was 35%, and their output was enriched for lymphoid fates. Conversely, hMPP output was enriched for myeloid-restricted fates. Distinguishing HSC from eMPP outputs revealed that only ~15% of adult HSC clones underwent multilineage differentiation (lymphoid, myeloid, and erythroid). To prospectively identify eMPP, we developed PolySMART for joint profiling of PolyloxExpress RNA barcodes, surface markers, and transcriptomes, and we found that the plasma cell marker CD138 enriches for eMPP. CD138+ MPP are primed for self-renewal and toward lymphoid fate, and become largely but not completely replaced by CD138âˆ’ MPP over time, which may contribute to the loss of lymphoid output with age. Taken together, adult hematopoiesis consists of two distinct lineage trees. The source of the â€œeMPP treeâ€ substantially contributes to hematopoiesis before it declines, while the HSC-hMPP tree supplies hematopoiesis life-long. Our molecular determinants distinguishing the two MPP systems may open avenues to further explore these unexpected layers of hematopoiesis.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272588" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE306525 åˆ©ç”¨å¤šæ¨¡æ€å•ç»†èƒåˆ†æè§£æäººç±»å…ç–«ç»†èƒåœ¨ç—…æ¯’å’ŒåŒ–å­¦ç‰©è´¨æš´éœ²ä¸‹çš„è¡¨è§‚åŸºå› ç»„åŠ¨æ€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€TMEã€cardiacã€gliomaã€DepMapã€depmapã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Irem B Gunduz ; Bei Wei ; Aaron J Wilk ; Madeline J Lee ; Catherine Blish ; Fabian Muller ; William J GreenleafSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensPathogen and chemical exposures lead to profound remodeling of the gene-regulatory landscape across human immune cell populations. Here, we present a single-nucleus chromatin accessibility atlas of human immune cells of individuals exposed to HIV-1, COVID-19, Influenza virus, organophosphates as well as healthy controls that provides insights into gene regulation driven by these cell-extrinsic stimuli. This atlas comprises 271,299 cells and 319,420 candidate regulatory elements that exhibited dynamic accessibility associated with gene expression across immune cell states. Our longitudinal HIV cohort revealed epigenetic signatures of T cell exhaustion, manifested in changes in the accessibility of binding sites for the FOXP family transcription factors. We further identified changes in the accessibility of candidate regulatory elements in CD14 monocytes upon SARS-CoV-2 exposure that are associated with a switch in NF-ÎºB to AP-1-based regulation of cytokine networks. By integrating single-cell profiles of DNA methylation from matched samples we create a multimodal epigenome atlas of human immune cells across exposure states using the accessibility-derived candidate regulatory elements. Both modalities exhibit complementary epigenetic signatures at transcription factor binding sites associated with cell state, as exemplified in the process of memory formation in T-cells. Finally, by linking potentially regulatory DNA methylation signatures to changes in chromatin accessibility in monocytes, we identify AP1 motifs exhibiting epigenetic dynamics, indicating selective remodeling in TF networks in severe cases of COVID-19.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306525" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE305657 æ…¢æ€§åº”æ¿€ç ´åè‚è„çŠ¬å°¿æ°¨é…¸é€”å¾„ï¼Œä»è€ŒæŠ‘åˆ¶è‚è„ CD8+ T ç»†èƒå…ç–«å¹¶ä¿ƒè¿›è‚ç™Œå‘ç”Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€DepMapã€depmapã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€proteomeã€Seuratã€Scanpyã€histoneã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Renhui SunSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusChronic psychological stress is associated with liver disease mortality, yet the reasons are unclear. Here we describe a stress-responsive brain-liver regulatory circuit that impairs CD8+T cell immunity and promotes the progression of liver cancer. Specifically, psychological stress-mediated dysregulation of catecholamine/Î²2-adrenergic receptor (ADRB2) signaling leads to reduced number and effector functions of liver CD8+ T cells by suppressing the expression of quinolinate phosphoribosyl transferase (QPRT) in hepatocytes and shifting hepatic Kyn metabolism from de novo nicotinamide adenine dinucleotide (NAD+) synthesis to kynurenic acid (KA) production. Notably, ADRB2/QPRT expression in human hepatocytes correlates with NAD+ and KA levels, as well as CD8+T cells frequency and function in human liver tissues.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305657" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE243826 é‡ç”Ÿå‹å’ŒATF6è½¬åŸºå› å°é¼ è‚è„å…ç–«ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„å­¦ç‰¹å¾åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€gliomaã€resistanceã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€Scanpyã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kristian Unger ; Mathias HeikenwÃ¤lder ; Xin LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHepatocellular carcinoma (HCC) is the fastest growing cause of cancer-related mortality with limited therapies. While endoplasmic reticulum (ER)-stress and the unfolded protein response (UPR) are implicated in HCC, the involvement of the UPR-transducer activating transcription factor 6 alpha (ATF6Î±) remains unclear. We isolated CD45+ cells from livers of wild type and hepatocyte-specific nATF6 overexprerssion mice for scRNAseq to decrible the the immune cell population.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE243826" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE288484 å¯¹ PTEN è›‹ç™½ç¼ºé™·å‹å‰åˆ—è…ºè‚¿ç˜¤çš„è½¬å½•ç½‘ç»œåˆ†ææ­ç¤ºäº†æ˜¾è‘—çš„åŸºè´¨é‡ç¼–ç¨‹å’Œè¡°è€æ—åˆ†æ³Œé€šè®¯çš„è¿¹è±¡ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€scRNAã€scDNAã€scATACã€spatialã€genomeã€transcriptomeã€proteomeã€Seuratã€epigeneticã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ivana Rondon-Lorefice ; Jose I Lopez ; Aitziber Ugalde-Olano ; Maite Zufiaurre ; Ianire Astobiza ; Natalia Martin-Martin ; Laura Bozal-Basterra ; Saioa Garcia-Longarte ; Amaia Zabala ; Sofia Rey ; Aida Santos-Martin ; Miguel Unda ; Ana Loizaga-Iriarte ; Mariona Graupera ; Paolo Nuciforo ; Arkaitz Carracedo ; Isabel MendizabalSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAmong the extensive genomic alterations in prostate cancer, PTEN deletion stands out as one of the most consistently observed events. PTEN loss in prostate tumors is primarily associated with cancer cell proliferation and survival through the activation of the PI3K-AKT-mTOR signaling pathway. However, the use as a robust biomarker in clinical practice is hampered by its complex epigenetic, transcriptional, and post-translational regulation. In situ protein assessment by immunohistochemistry (IHC) captures PTEN protein status, but it does not report on associated tumor microenvironment remodeling. Here, we undertook an approach that combined PTEN immunoreactivity analysis with high-throughput transcriptional analysis to gain insights into the downstream functional effects of PTEN protein loss in primary tumors. Our extensive bioinformatic analyses highlighted stromal remodeling as a prominent cancer cell-extrinsic process associated with PTEN loss. By extending our transcriptomic computational strategy to Pten-loss driven murine prostate cancer, we validated the causal role of Pten in the stromal reaction observed in clinical specimens. Mechanistically, we provide experimental evidence for the activation of a paracrine program that encompasses enhanced TGF-Î² signaling and that is compatible with the secretome of PTEN-deficient senescent cancer cells. Finally, our findings enable the sub-stratification of tumors with PTEN loss based on their senescence-associated stroma remodeling program to distinguish indolent from aggressive cases. Our study provides relevant biological context to the cellular and molecular alterations unleashed upon PTEN protein loss in prostate cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288484" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE281103 TGF-Î²é©±åŠ¨çš„Mafbé€šè¿‡ç«äº‰æ€§ç»“åˆWTAPå‡å¼±IGFBP2çš„é™è§£ä¿®é¥°ï¼Œè¯±å¯¼åµå·¢ç™Œè½¬ç§»å’Œå…ç–«å¤±è°ƒã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€metabolicã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€scRNAã€scDNAã€scATACã€Visiumã€genomeã€Seuratã€Scanpyã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qinke Li ; Qiang Yi ; Siying Zhang ; Zhu YangSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis ChIP-seq dataset examines the genome-wide binding profile of transcription factor MAFB in ovarian cancer cells to investigate its role in tumor progression and immune dysregulation. Using ID8 mouse ovarian cancer cells with MAFB overexpression, we performed chromatin immunoprecipitation followed by high-throughput sequencing to identify MAFB binding sites. Surprisingly, our analysis revealed that IGFBP2, a key mediator of MAFB-driven tumor metastasis and immune modulation, was not a direct transcriptional target of MAFB. The ChIP-seq data was generated using an anti-MAFB antibody, with IgG as control. Peak calling was performed using MACS2 (version 2.2.7.1), and peak annotation was conducted using the ChIPseeker R package. Motif analysis was performed with HOMER (v4.11.1), and differential analysis was conducted with MAnorm.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281103" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE306588 ç§»æ¤è‚¾ä¸­æ ¸ç£·è›‹ç™½ 1 ä¹³é…¸åŒ–è¯±å¯¼é“æ­»äº¡è§¦å‘æ³¢ï¼ŒåŠ å‰§ç§»æ¤è‚¾åŠŸèƒ½å»¶è¿Ÿæ¢å¤ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€cardiacã€kinaseã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€Scanpyã€epigeneticã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xinyuan Li ; Xin Gou ; Tianxin Lin ; Weiyang HeSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe effects of NPM1 lactylation on transcriptional profiling in HK-2 cells<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306588" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE217362 é¢…éª¨æ¥æºé—´å……è´¨å¹²ç»†èƒç§»æ¤å¯¹å®éªŒæ€§è„Šé«“æŸä¼¤åŠŸèƒ½æ¢å¤çš„å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€DepMapã€depmapã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€Scanpyã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Kiyoharu ShimizuSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusWe compared the therapeutic effects and mechanism of transplanted rat cranial bone-derived mesenchmay stem cell (rcMSCs) and rat bone marrow-derived mesenchymal stem cell (rbMSCs) in a rat cervical spinal cord injury (cSCI) model.We performed gene expression profiling analysis using data obtained from RNA-seq of rcMSCs and rbMSCs<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217362" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE309248 åˆ©ç”¨äººè¯±å¯¼å¤šèƒ½å¹²ç»†èƒç”Ÿæˆè„Šé«“ç±»å™¨å®˜ï¼Œå¹¶ä½¿å…¶å‘è…°æ¤æ–¹å‘åˆ†åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€TMEã€gliomaã€TCGAã€single.cellã€scRNAã€scDNAã€spatialã€genomeã€genomicsã€transcriptomeã€proteomeã€Seuratã€epigenomeã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Jun Loh ; Joel Mason ; Pratibha Panwar ; Shila Ghazanfar ; Kwaku Dad Abu-Bonsrah ; Forough Habibollahi ; Brett J Kagan ; Bradley Turner ; Samantha K BartonSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensOrganoids offer a powerful platform to model human development and disease in vitro while preserving key features of in vivo tissue architecture and complexity. In this study, we developed a novel, reproducible protocol to generate human induced pluripotent stem cell (iPSC)-derived spinal cord organoids specifically patterned to the lumbar region, a segment rarely modelled in vitro. These organoids recapitulate the ventral spinal cordâ€™s cytoarchitecture and exhibit functional neuronal activity, providing a physiologically relevant system for investigating human spinal cord development and neurodegenerative disease mechanisms. Furthermore, we applied 10x Genomics single-cell RNA sequencing to generate the first high-resolution transcriptional map of human lumbar spinal cord organoids, revealing their cellular diversity and molecular signatures.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309248" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 30 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>é¶å‘ ATM-TGS1-BRCA1 è½´å…‹æœèƒ°è…ºç™Œçš„é—ä¼ æ¯’æ€§æ²»ç–—è€è¯æ€§ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒ°è…ºç™Œ ï¼ˆPAADï¼‰ ä»ç„¶æ˜¯æœ€è‡´å‘½çš„æ¶æ€§è‚¿ç˜¤ä¹‹ä¸€ï¼Œä¸»è¦æ˜¯å› ä¸ºå®ƒå¯¹åŒ–ç–—å’Œæ”¾ç–—ç­‰é—ä¼ æ¯’æ€§ç–—æ³•å…·æœ‰å¾ˆå¼ºçš„è€è¯æ€§ã€‚äº†è§£è¿™ç§è€è¯æ€§çš„æ½œåœ¨æœºåˆ¶å¯¹äºæ”¹å–„ä¸´åºŠç»“æœè‡³å…³é‡è¦ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬ç¡®å®šäº†ä¸‰ç”²åŸºé¸Ÿè‹·åˆé…¶ 1 ï¼ˆTGS1ï¼‰ ä»¥å‰ä»¥å…¶åœ¨ RNA ä¿®é¥°ä¸­çš„ä½œç”¨è€Œé—»åï¼Œä½œä¸ºåŒæºé‡ç»„ ï¼ˆHRï¼‰ ä¿®å¤çš„å…³é”®ä»‹è´¨ï¼Œç‰¹åˆ«æœ‰åŠ©äº PAAD çš„è€è¯æ€§ã€‚TGS1 åœ¨ PAAD ç»„ç»‡ä¸­æ˜¾è‘—è¿‡è¡¨è¾¾ï¼Œä¸æ™šæœŸç–¾ç—…åˆ†æœŸã€æ²»ç–—è€è¯å’Œæ‚£è€…é¢„åä¸è‰¯å¯†åˆ‡ç›¸å…³ã€‚DNA æŸä¼¤åï¼ŒATM æ¿€é…¶åœ¨ä¸æ°¨é…¸æ®‹åŸº S389 å’Œ S531 å¤„ç£·é…¸åŒ– TGS1ï¼Œè¿™ä»‹å¯¼å…¶ä¸ BRCA1 çš„ç›´æ¥ç›¸äº’ä½œç”¨ä»¥åŠéšåå°† BRCA1 å‹Ÿé›†åˆ° DNA æŸä¼¤ä½ç‚¹ã€‚ç£·é…¸åŒ–ä¾èµ–æ€§ç›¸äº’ä½œç”¨æé«˜äº† HR ä¿®å¤æ•ˆç‡ï¼Œä½¿ç™Œç»†èƒèƒ½å¤Ÿåœ¨é—ä¼ æ¯’æ€§åº”æ¿€ä¸­å­˜æ´»ä¸‹æ¥ã€‚TGS1 çš„è€—ç«­æˆ–è¯ç†å­¦æŠ‘åˆ¶è¯±å¯¼ HR ç¼ºä¹ï¼Œå¹¶æ˜¾ç€å¢å¼ºå¯¹ DNA æŸä¼¤å‰‚çš„æ•æ„Ÿæ€§ï¼Œç‰¹åˆ«æ˜¯ PARP æŠ‘åˆ¶å‰‚ï¼Œåœ¨ä½“å¤– PAAD ç»†èƒç³»<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1985821783648542720/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Answer ALS å®Œæˆäº†å®Œæ•´æ•°æ®é›†çš„å‘å¸ƒï¼Œå¹¶å°† ALS TDI ARC ç ”ç©¶æ•°æ®æ•´åˆåˆ° Neuromine ä¸­ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€cardiacã€scRNAã€scDNAã€scATACã€spatialã€genomeã€proteomeã€Seuratã€epigenome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAnswer ALS and ALS TDI data integration in Neuromine offers researchers RNA sequencing and multi-omics insights from over 2,500 ALS patient profiles to accelerate therapy...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/answer-als-completes-release-of-full-dataset-and-integrates-als-tdi-arc-study-data-into-neuromine/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>KATMAPé€šè¿‡åŸºå› æ•²ä½æ•°æ®æ¨æ–­å‰ªæ¥å› å­æ´»æ€§å’Œè°ƒæ§é¶ç‚¹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€TMEã€TCGAã€scRNAã€scDNAã€scATACã€spatialã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing reveals how KATMAP predicts splicing factor activity and regulatory targets, offering new insights into RNA processing and gene regulation...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/katmap-infers-splicing-factor-activity-and-regulatory-targets-from-knockdown-data/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>Nicheformerâ€”â€”ä¸€ç§æ­ç¤ºç»†èƒåœ¨ç»„ç»‡ä¸­å¦‚ä½•ç»„ç»‡çš„æ–°å‹åŸºç¡€æ¨¡å‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€TCGA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing combined with spatial transcriptomics allows Nicheformer to reconstruct cellular neighborhoods, revealing how tissue structure and gene expression are...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/nicheformer-a-new-foundation-model-that-reveals-how-cells-are-organized-in-tissues/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>TME</td>
<td>39</td>
</tr>
<tr>
<td>scRNA</td>
<td>38</td>
</tr>
<tr>
<td>Seurat</td>
<td>35</td>
</tr>
<tr>
<td>cancer</td>
<td>33</td>
</tr>
<tr>
<td>scDNA</td>
<td>33</td>
</tr>
<tr>
<td>genome</td>
<td>32</td>
</tr>
<tr>
<td>scATAC</td>
<td>30</td>
</tr>
<tr>
<td>spatial</td>
<td>26</td>
</tr>
<tr>
<td>glioma</td>
<td>25</td>
</tr>
<tr>
<td>tumor</td>
<td>24</td>
</tr>
<tr>
<td>TCGA</td>
<td>20</td>
</tr>
<tr>
<td>cardiac</td>
<td>18</td>
</tr>
<tr>
<td>genomics</td>
<td>18</td>
</tr>
<tr>
<td>histone</td>
<td>17</td>
</tr>
<tr>
<td>Scanpy</td>
<td>16</td>
</tr>
<tr>
<td>proteome</td>
<td>15</td>
</tr>
<tr>
<td>carcinoma</td>
<td>13</td>
</tr>
<tr>
<td>immune</td>
<td>12</td>
</tr>
<tr>
<td>DepMap</td>
<td>12</td>
</tr>
<tr>
<td>depmap</td>
<td>12</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (3æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498735&amp;idx=1&amp;sn=e01b6beac1b9224906c321a427005cf4" target="_blank" rel="noopener noreferrer">æ–‡çŒ®åˆ†äº«--AIé©±åŠ¨çš„ç©ºé—´ç»†èƒè¡¨å‹ç»„å­¦æå‡éå°ç»†èƒè‚ºç™Œé£é™©åˆ†å±‚æ•ˆèƒ½</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821264&amp;idx=2&amp;sn=736efee365ebe9a8dfe31b4ca92963ef" target="_blank" rel="noopener noreferrer">å½“å¤§å®¶æ‰å †åšä¹³é…¸çš„æ—¶å€™ï¼Œæœºæ™ºçš„æˆ‘å·å·çš„çœ‹ä¸Šäº†è¿™ä¸ªä»£è°¢ç‰©â€¦â€¦.</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821264&amp;idx=1&amp;sn=c38904b3643acd55740c86e051165314" target="_blank" rel="noopener noreferrer">å¦‚æœä½ æƒ³ä»ä»£è°¢è§’åº¦ç”³è¯·å›½è‡ªç„¶ï¼Œæ¨èå››ä¸ªé«˜ç«¯æ€è·¯ç»™ä½ â€¦â€¦</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (30æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242831" target="_blank" rel="noopener noreferrer">GSE242831 é‡ç”Ÿå‹å°é¼ å’Œ ATF6 è½¬åŸºå› å°é¼ è‚è„ç»„ç»‡çš„åŸºå› ç»„æ‹·è´æ•°ç‰¹å¾ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217688" target="_blank" rel="noopener noreferrer">GSE217688 å¡æ³¢è¥¿è‚‰ç˜¤ç›¸å…³ç–±ç–¹ç—…æ¯’é€šè¿‡è°ƒèŠ‚å‡å°¿è‹·é€”å¾„å¢å¼ºè£‚è§£æ€§å¤åˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290937" target="_blank" rel="noopener noreferrer">GSE290937 å¤šç»„å­¦åˆ†ææ¶ç—…è´¨é¶ç»„ç»‡æ­ç¤ºäº†å¯¹ç™Œç—‡çš„æ—¶ç©ºåè°ƒååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308378" target="_blank" rel="noopener noreferrer">GSE308378 æœ€å°ç¼–è¾‘ï¼Œæœ€å¤§æ•ˆåº”ï¼šå•æ°¨åŸºé…¸ç¼ºå¤±çš„ SCID çŒªå»¶é•¿ç”Ÿå­˜æœŸ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295294" target="_blank" rel="noopener noreferrer">GSE295294 å¤§é¼ èƒç›˜MATE1ç‰¹å¼‚æ€§è¡¨è¾¾å¯¼è‡´äºŒç”²åŒèƒå’Œ1-ç”²åŸº-4-è‹¯åŸºå¡å•¶åœ¨èƒå„¿è½¬è¿ä¸­çš„ç‰©ç§å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294466" target="_blank" rel="noopener noreferrer">GSE294466 äººç±»é¢ˆåŠ¨è„‰æ–‘å—çš„ Xenium ç©ºé—´è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294291" target="_blank" rel="noopener noreferrer">GSE294291 äººç±»é¢ˆåŠ¨è„‰æ–‘å—å•ç»†èƒè½¬å½•ç»„å­¦ V2</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293415" target="_blank" rel="noopener noreferrer">GSE293415 å°é¼ åµå­å‘ç”Ÿå’Œæ¤å…¥å‰èƒšèƒå‘è‚²è¿‡ç¨‹ä¸­H2A.Zæºå…¥çš„ä¸»è¦æµªæ½®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244213" target="_blank" rel="noopener noreferrer">GSE244213 6æœˆé¾„é‡ç”Ÿå‹å’Œè‚ç»†èƒç‰¹å¼‚æ€§ATF6è¿‡è¡¨è¾¾å°é¼ çš„è‚è„è½¬å½•ç»„è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244212" target="_blank" rel="noopener noreferrer">GSE244212 3æœˆé¾„é‡ç”Ÿå‹å’Œè‚ç»†èƒç‰¹å¼‚æ€§ATF6è¿‡è¡¨è¾¾å°é¼ çš„è‚è„è½¬å½•ç»„è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308949" target="_blank" rel="noopener noreferrer">GSE308949 è‚ºè‚‰èŠ½è‚¿ä¸­ç»“æ ¸åˆ†ææ†èŒè‚½ç‰¹å¼‚æ€§Tç»†èƒçš„è½¬å½•è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308377" target="_blank" rel="noopener noreferrer">GSE308377 æœ€å°ç¼–è¾‘ï¼Œæœ€å¤§æ•ˆåº”ï¼šå•æ°¨åŸºé…¸ç¼ºå¤±çš„ SCID çŒªå»¶é•¿ç”Ÿå­˜æœŸ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306531" target="_blank" rel="noopener noreferrer">GSE306531 ç§»æ¤è‚¾ä¸­æ ¸ä»ç£·è›‹ç™½1ä¹³é…¸åŒ–è¯±å¯¼é“æ­»äº¡è§¦å‘æ³¢ï¼ŒåŠ å‰§ç§»æ¤è‚¾åŠŸèƒ½å»¶è¿Ÿæ¢å¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281599" target="_blank" rel="noopener noreferrer">GSE281599 ç»„ç»‡ç²˜é™„æ€§ã€æŠ—èŒæ€§å’ŒæŠ—æ°§åŒ–æ€§æ°´å‡èƒ¶å¯†å°å‰‚ï¼Œç”¨äºå¯†å°ç»“ç›´è‚ å»åˆå£æ¼å¹¶é¢„é˜²æœ¯åç²˜è¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248865" target="_blank" rel="noopener noreferrer">GSE248865 çƒ­é‡é™åˆ¶å’Œçš®è´¨é…®æ²»ç–—å¼•èµ·çš„ç³–çš®è´¨æ¿€ç´ å—ä½“é¡ºå¼é‡ç¼–ç¨‹ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281186" target="_blank" rel="noopener noreferrer">GSE281186 PRMT3ä»‹å¯¼çš„è„‘è‚¿ç˜¤å¹²ç»†èƒçš„ç»†èƒå’Œåˆ†å­è°ƒæ§ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292505" target="_blank" rel="noopener noreferrer">GSE292505 æ°¡æš´éœ²å»¶ç¼“é“¶å±‘ç—…å°é¼ æ¨¡å‹ä¸­çš®è‚¤ç—…å˜çš„å‘ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276603" target="_blank" rel="noopener noreferrer">GSE276603 CFAP20 æŒ½æ•‘äº†é˜»æ»çš„ RNAPIIï¼Œä½¿å…¶æ— æ³•è¿›å…¥åŒå‘å¤åˆ¶ä½“è·¯å¾„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295750" target="_blank" rel="noopener noreferrer">åˆ©ç”¨ç”µè·æ”¹å˜å‹å¯é‡Šæ”¾è½¬è¿ä½“å°†GSE295750 RNAé€’é€è‡³è§’è†œå†…çš®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287187" target="_blank" rel="noopener noreferrer">GSE287187 Chameau (HBO1) åœ¨æœè‡ä¸­ä»¥æ¸©åº¦ä¾èµ–çš„æ–¹å¼è°ƒæ§é¥¥é¥¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301362" target="_blank" rel="noopener noreferrer">GSE301362 è¡°è€ç»†èƒæ¸…é™¤ç–—æ³•è¯†åˆ«å¹¶é€†è½¬ç»†èƒè¡°è€ï¼Œä»è€Œæ­ç¤ºå…¶ä½œä¸ºè‚ é“å†ç”Ÿå’ŒåŠŸèƒ½éšœç¢ï¼ˆä¸è¡°è€ç›¸å…³ï¼‰é©±åŠ¨å› ç´ çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298149" target="_blank" rel="noopener noreferrer">GSE298149 çƒ­é‡é™åˆ¶çš„ç»“æœæ˜¯ç”±å¢å¼ºçš„ç³–çš®è´¨æ¿€ç´ èŠ‚å¾‹é©±åŠ¨çš„ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248866" target="_blank" rel="noopener noreferrer">GSE248866 çƒ­é‡é™åˆ¶çš„ç»“æœæ˜¯ç”±å¢å¼ºçš„ç³–çš®è´¨æ¿€ç´ èŠ‚å¾‹é©±åŠ¨çš„ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248864" target="_blank" rel="noopener noreferrer">GSE248864 è‚è„ç³–çš®è´¨æ¿€ç´ å—ä½“ (GR) é©±åŠ¨å¯¹çƒ­é‡é™åˆ¶çš„æ˜¼å¤œé€‚åº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285470" target="_blank" rel="noopener noreferrer">GSE285470 ä»£è°¢ç¨³æ€ç³»ç»Ÿè°ƒèŠ‚å¿…éœ€ä»£è°¢ç‰©çš„èšé›†å’Œæ¯’æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288422" target="_blank" rel="noopener noreferrer">GSE288422 ç ”ç©¶å‘ç° KRT17 è¡¨è¾¾å‡é«˜å¯å¢å¼ºé“‚è€è¯åµå·¢ç™Œç±»å™¨å®˜å¯¹é¶å‘æ²»ç–—çš„æ•æ„Ÿæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217588" target="_blank" rel="noopener noreferrer">GSE217588 æº¶è´¨è½½ä½“å®¶æ—37æˆå‘˜3åœ¨è‚ç»†èƒç™Œä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277042" target="_blank" rel="noopener noreferrer">GSE277042ï¼šArmh4å¯¹è¡°è€å½±å“çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249285" target="_blank" rel="noopener noreferrer">GSE249285 ä½“å¤–è‚ºç±»å™¨å®˜æ¨¡å‹ç”¨äºå¼‚å¸¸åŸºåº•æ ·ç»†èƒçš„è¯±å¯¼å’Œæ¿€æ´»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281155" target="_blank" rel="noopener noreferrer">GSE281155 RNA-seq åˆ†æäº†ç» DEHP å¤„ç†çš„ Sox9-eGFP å°é¼ èƒå„¿ç¾ä¸¸çš„ RNA-seq æ•°æ®ã€‚</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-05 21:37</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>